Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Drug Resistance

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    February 2024
  1. SAUVE K, Watson A, Oh JT, Swift S, et al
    The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.
    J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093.
    PubMed     Abstract available


  2. HENRY SA, Webster CM, Shaw LN, Torres NJ, et al
    Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Feb 13:jiad540. doi: 10.1093.
    PubMed     Abstract available


    January 2024
  3. XIONG YQ, Li Y, Goncheva MI, Elsayed AM, et al
    The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
    J Infect Dis. 2024 Jan 31:jiad577. doi: 10.1093.
    PubMed     Abstract available


    November 2023
  4. PHILLIPS LT, Witney AA, Furegato M, Laing KG, et al
    Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.
    J Infect Dis. 2023;228:1179-1188.
    PubMed     Abstract available


    July 2023
  5. HERRERA AL, Chaussee MS, Pietri JE
    Experimental acquisition, maintenance, and transmission of methicillin-resistant Staphylococcus aureus (MRSA) by the common bed bug, Cimex lectularius.
    J Infect Dis. 2023 Jul 31:jiad302. doi: 10.1093.
    PubMed     Abstract available


  6. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    PubMed     Abstract available


  7. HU Z, Cordwell T, Nguyen H, Li J, et al
    Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of HIV-1 Subtype A6.
    J Infect Dis. 2023 Jul 27:jiad291. doi: 10.1093.
    PubMed     Abstract available


  8. SHIELDS RK
    Progress and new challenges in combatting the threat of antimicrobial resistance: Perspective from an Infectious Diseases pharmacist.
    J Infect Dis. 2023 Jul 24:jiad250. doi: 10.1093.
    PubMed    


  9. TANG Y, Liu X, Chen W, Luo X, et al
    Antimicrobial Resistance Profiling and Genome Analysis of the penA-60.001 Neisseria gonorrhoeae Clinical Isolates in China in 2021.
    J Infect Dis. 2023 Jul 18:jiad258. doi: 10.1093.
    PubMed     Abstract available


    June 2023
  10. NORGAARD JC, Jorgensen M, Moestrup KS, Ilett EE, et al
    Impact of Antibiotic Treatment on the Gut Microbiome and its Resistome in Hematopoietic Stem Cell Transplant Recipients.
    J Infect Dis. 2023;228:28-36.
    PubMed     Abstract available


  11. SINGH DK, Bhaskar A, Pahuja I, Shaji A, et al
    Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant tuberculosis by inducing polyfunctional central memory T cell responses.
    J Infect Dis. 2023 Jun 8:jiad214. doi: 10.1093.
    PubMed     Abstract available


    May 2023
  12. SCHALKWIJK HH, Georgala A, Gillemot S, Temblador A, et al
    A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
    J Infect Dis. 2023 May 24:jiad184. doi: 10.1093.
    PubMed     Abstract available


  13. FORD L, Shah HJ, Eikmeier D, Hanna S, et al
    Antimicrobial-resistant nontyphoidal Salmonella infection following international travel - United States, 2018-2019.
    J Infect Dis. 2023 May 2:jiad128. doi: 10.1093.
    PubMed     Abstract available


    April 2023
  14. VAN DER HEIJDEN YF, Maruri F, Blackman A, Morrison R, et al
    Mycobacterium tuberculosis gene expression associated with fluoroquinolone resistance and efflux pump inhibition.
    J Infect Dis. 2023 Apr 20:jiad112. doi: 10.1093.
    PubMed     Abstract available


  15. BRISTOW CC, Mortimer TD, Morris S, Grad YH, et al
    Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
    J Infect Dis. 2023;227:917-925.
    PubMed     Abstract available


    October 2022
  16. CALIX JJ, de Almeida MCS, Potter RF, Wallace MA, et al
    Outpatient clonal propagation propelled rapid regional establishment of an emergent carbapenem-resistant Acinetobacter baumannii lineage ST499Pas.
    J Infect Dis. 2022 Oct 27. pii: 6775876. doi: 10.1093.
    PubMed     Abstract available


  17. ESHLEMAN SH, Fogel JM, Halvas EK, Piwowar-Manning E, et al
    HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention.
    J Infect Dis. 2022 Oct 14. pii: 6761331. doi: 10.1093.
    PubMed     Abstract available


    September 2022
  18. SMITH MSR, Mohan H, Ajaykumar A, Hsieh AYY, et al
    Second-generation HIV integrase inhibitors induce differentiation dysregulation and exert toxic effects in human embryonic stem cell and mouse models.
    J Infect Dis. 2022 Sep 19. pii: 6704757. doi: 10.1093.
    PubMed     Abstract available


  19. MARGOT NA, Naik V, VanderVeen L, Anoshchenko O, et al
    Resistance analyses in Highly Treatment-Experienced People with HIV Treated with the Novel Capsid HIV Inhibitor Lenacapavir.
    J Infect Dis. 2022 Sep 9. pii: 6694734. doi: 10.1093.
    PubMed     Abstract available


  20. CHOU S, Song K, Wu J, Bo T, et al
    Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection.
    J Infect Dis. 2022;226:576-584.
    PubMed     Abstract available


    August 2022
  21. SANTOS BRAVO M, Plault N, Sanchez-Palomino S, Rodriguez C, et al
    Genotypic and phenotypic study of antiviral resistance mutations in refractory cytomegalovirus infection.
    J Infect Dis. 2022 Aug 22. pii: 6672993. doi: 10.1093.
    PubMed     Abstract available


  22. THIEDE SN, Snitkin ES, Trick W, Payne D, et al
    Genomic Epidemiology Suggests Community Origins of Healthcare-Associated USA300 Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2022;226:157-166.
    PubMed     Abstract available


    June 2022
  23. JOHNSON JR, Clabots C, Porter SB, Bender T, et al
    Intestinal Persistence of Colonizing Escherichia coli Strains, Especially ST131-H30, in Relation to Bacterial and Host Factors.
    J Infect Dis. 2022;225:2197-2207.
    PubMed     Abstract available


    May 2022
  24. WU D, Chen Y, Sun L, Yu Y, et al
    Community Origins of Healthcare-Associated CC59 Methicillin-Resistant Staphylococcus aureus in China.
    J Infect Dis. 2022 May 20. pii: 6589835. doi: 10.1093.
    PubMed    


    February 2022
  25. SMITH RA, Wu VH, Song J, Raugi DN, et al
    Spectrum of Activity of Raltegravir and Dolutegravir Against Novel Treatment-Associated Mutations In HIV-2 Integrase: A Phenotypic Analysis Using An Expanded Panel of Site-Directed Mutants.
    J Infect Dis. 2022 Feb 3. pii: 6521074. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  26. SHAIK S, Suresh A, Ahmed N
    Genome Dynamics and Evolution of Multiple-Drug-Resistant Bacteria: Implications for Global Infection Control Priorities.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  27. DYSON ZA, Holt KE
    Five Years of GenoTyphi: Updates to the Global Salmonella Typhi Genotyping Framework.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  28. PEREIRA-DIAS J, Nguyen Ngoc Minh C, Tran Thi Hong C, Nguyen Thi Nguyen T, et al
    The Gut Microbiome of Healthy Vietnamese Adults and Children Is a Major Reservoir for Resistance Genes Against Critical Antimicrobials.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


    November 2021
  29. VEERARAGHAVAN B, Pragasam AK, Ray P, Kapil A, et al
    Evaluation of Antimicrobial Susceptibility Profile in Salmonella Typhi and Salmonella Paratyphi A: Presenting the Current Scenario in India and Strategy for Future Management.
    J Infect Dis. 2021;224.
    PubMed     Abstract available


  30. LI Y, Dominguez S, Nanduri SA, Rivers J, et al
    Genomic Characterization of Group A Streptococci Causing Pharyngitis and Invasive Disease in Colorado, USA, June 2016 - April 2017.
    J Infect Dis. 2021 Nov 12. pii: 6426048. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  31. KARIUKI S, Wairimu C, Mbae C
    Antimicrobial Resistance in endemic enteric infections in Kenya and the region, and efforts towards addressing the challenges.
    J Infect Dis. 2021 Sep 22. pii: 6373876. doi: 10.1093.
    PubMed     Abstract available


  32. SANTOS BRAVO M, Plault N, Sanchez Palomino S, Mosquera Gutierrez MM, et al
    Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients.
    J Infect Dis. 2021;224:1024-1028.
    PubMed     Abstract available


  33. SAHA SK, Tabassum N, Saha S
    Typhoid Conjugate Vaccine - an urgent tool to combat typhoid, and tackle antimicrobial resistance.
    J Infect Dis. 2021 Sep 16. pii: 6371004. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  34. PALICH R, Teyssou E, Sayon S, Abdi B, et al
    Kinetics of archived M184V mutation in treatment-experienced virally suppressed HIV-infected patients.
    J Infect Dis. 2021 Aug 20. pii: 6355381. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  35. DUCARMON QR, Kuijper EJ, Olle B
    Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  36. GERARDIN Y, Timberlake S, Allegretti JR, Smith MB, et al
    Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome.
    J Infect Dis. 2021;223.
    PubMed     Abstract available


  37. PETTIGREW MM, Tanner W, Harris AD
    The Lung Microbiome and Pneumonia.
    J Infect Dis. 2021;223.
    PubMed    


    April 2021
  38. GOLOB JL, Rao K
    Signal vs. noise: how to analyze the microbiome and make progress on antimicrobial resistance.
    J Infect Dis. 2021 Apr 21. pii: 6242384. doi: 10.1093.
    PubMed    


  39. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
    J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  40. ZHOU S, Sizemore S, Moeser M, Zimmerman S, et al
    Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.
    J Infect Dis. 2021;223:876-884.
    PubMed     Abstract available


  41. RICH SN, Poschman K, Hu H, Mavian C, et al
    Sociodemographic, Ecological, and Spatiotemporal Factors Associated with Human Immunodeficiency Virus Drug Resistance in Florida: A Retrospective Analysis.
    J Infect Dis. 2021;223:866-875.
    PubMed     Abstract available


    February 2021
  42. POPOVICH KJ
    Using Genomic Sequencing to Delineate Community Networks of Methicillin-Resistant Staphylococcus aureus Transmission Among Men Who Have Sex With Men.
    J Infect Dis. 2021;223:543-546.
    PubMed    


  43. BANHART S, Selb R, Oehlmann S, Bender J, et al
    The mosaic mtr locus as major genetic determinant of azithromycin resistance of Neisseria gonorrhoeae, Germany, 2018.
    J Infect Dis. 2021 Feb 16. pii: 6138844. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  44. PARK SY, Faraci G, Murphy G, Pilcher C, et al
    Microdrop HIV sequencing for incidence and drug resistance surveillance.
    J Infect Dis. 2021 Jan 31. pii: 6124747. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  45. BERTAGNOLIO S, Hermans L, Jordan MR, Avila-Rios S, et al
    Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020 Nov 17. pii: 5986606. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  46. IKEUCHI K, Adachi E, Sasaki T, Suzuki M, et al
    An outbreak of USA300 MRSA among people with HIV in Japan.
    J Infect Dis. 2020 Oct 15. pii: 5923726. doi: 10.1093.
    PubMed     Abstract available


  47. HJORT K, Juren P, Toro JC, Hoffner S, et al
    Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
    J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
    PubMed     Abstract available


  48. PICKERING H, Chernet A, Sata E, Zerihun M, et al
    Genomics of Ocular Chlamydia trachomatis after 5 years of SAFE interventions for trachoma in Amhara, Ethiopia.
    J Infect Dis. 2020 Oct 9. pii: 5920008. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.